The Influence of Bisphosphonates in the Oral Cavity in Children

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Completed
CT.gov ID
NCT00402064
Collaborator
(none)
60
1
21.1
2.8

Study Details

Study Description

Brief Summary

The use of bisphosphonates during childhood to ameliorate the skeletal abnormalities associated with osteogenesis imperfecta, idiopathic juvenile osteoporosis, fibrous dysplasia of bone and cerebral palsy. There is paucity of long-term studies among children regarding the safety and efficacy of bisphosphonates.

Osteomyelitis and necrosis of the jaws has been was discovered and reported as a serious adverse event in bisphosphonate-treated adults patients.

To our knowledge, there is no report in the literature about osteomyelitis in children treated with bisphosphonates and the influence of long term treatment with bisphosphonates on children's jaws, the reaction to extractions and on the oral cavity.

Aim of the study: to examine the influence in the oral cavity of bisphosphonate in children

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The use of bisphosphonates during childhood to ameliorate the skeletal abnormalities associated with osteogenesis imperfecta, idiopathic juvenile osteoporosis, fibrous dysplasia of bone and cerebral palsy. There is paucity of long-term studies among children regarding the safety and efficacy of bisphosphonates.

    Osteomyelitis and necrosis of the jaws has been was discovered and reported as a serious adverse event in bisphosphonate-treated adults patients.

    To our knowledge, there is no report in the literature about osteomyelitis in children treated with bisphosphonates and the influence of long term treatment with bisphosphonates on children's jaws, the reaction to extractions and on the oral cavity Aim of the study: to examine the influence in the oral cavity of bisphosphonate in children Materials and methods Population: 50 children treated with bisphosphonate will be included in the study.

    The following data will be recorded:
    1. age, gender, initial disease, age at diagnosis, additional diseases

    2. duration and dosage of the bisphosphonate medication (kind of bisphosphonate, age at the beginning of the drug treatment, duration of treatment, frequency of intake, additional medications)

    3. Clinical dental examination was performed for detection of; caries, gingival inflammation and oral hygiene, sequence of dental eruption, teeth extractions, and presence of exposure bone.

    4. Unstimulated whole saliva was collected using the spitting method as previously described. Sialochemistry analysis will be performed.

    5. Serum analysis findings including: calcium (Ca), phosphorous (P), alkaline phosphatase (AlP) and parathyroid hormone (PTH),vitamin D cross-linked telopeptides (ctx, ntx), bone density. (these examination are performed routinely, in these patients, as part of medical follow up.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Official Title:
    The Influence of Bisphosphonates in the Oral Cavity in Children
    Study Start Date :
    Mar 1, 2007
    Study Completion Date :
    Dec 1, 2008

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      2 Years to 20 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • children treated with bisphosphonate

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Hadassah scool of Dental Medicine Jerusalem Israel 91120

      Sponsors and Collaborators

      • Hadassah Medical Organization

      Investigators

      • Study Director: diana ram, DMD, lecturer, the Hebrew university, Hadassa school of dental medicine

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00402064
      Other Study ID Numbers:
      • st1975-HMO-CTIL
      First Posted:
      Nov 22, 2006
      Last Update Posted:
      Jan 29, 2009
      Last Verified:
      Jan 1, 2009
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Jan 29, 2009